Mostrar el registro sencillo del ítem
Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
| dc.contributor.author | García Carracedo, Dario | |
| dc.contributor.author | Villaronga Torres, María de los Ángeles | |
| dc.contributor.author | Álvarez Teijeiro, Saúl | |
| dc.contributor.author | Santamaría Ruiz de Azúa, Íñigo | |
| dc.contributor.author | Allonca Campa, Eva | |
| dc.contributor.author | Suárez Fernández, Laura | |
| dc.contributor.author | González Meana, María Victoria | |
| dc.contributor.author | Balbín Felechosa, Milagros | |
| dc.contributor.author | Astudillo González, María Aurora | |
| dc.contributor.author | Martínez Camblor, Pablo | |
| dc.contributor.author | Rodrigo Tapia, Juan Pablo | |
| dc.contributor.author | García Pedrero, Juana María | |
| dc.date.accessioned | 2017-02-01T07:40:06Z | |
| dc.date.available | 2017-02-01T07:40:06Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | Oncotarget, 7(20), p. 29780-29793 (2016); doi:10.18632/oncotarget.8957 | |
| dc.identifier.issn | 1949-2553 | |
| dc.identifier.uri | http://hdl.handle.net/10651/39672 | |
| dc.description.sponsorship | This study was supported by grants from the Plan Nacional de I+D+I 2008-2011 Instituto de Salud Carlos III (PI11/00929 to JPR) and Plan Nacional de I+D+I 2013-2016 ISCIII (CP13/00013 and PI13/00259 to JMGP),RD12/0036/0015 of Red Temática de Investigación Cooperativa en Cáncer (RTICC), Spain, and the FEDER Funding Program from the European Union. M.A.V. is recipient of a fellowship from ISCIII (CD13/00157). Work in the laboratory of G.S. was funded by grant NIH R01CA109525 | |
| dc.description.statementofresponsibility | García-Carracedo, D., Ángeles Villaronga, M., Álvarez-Teijeiro, S., Hermida-Prado, F., Santamaría, I., Allonca, E., Suárez-Fernández, L., Victoria Gonzalez, M., Milagros Balbín, M., Astudillo, A., Martínez-Camblor, P., Su, G.H., Rodrigo, J.P., García-Pedrero, J.M. | |
| dc.format.extent | p. 29780-29793 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Oncotarget | |
| dc.rights | CC Reconocimiento 3.0 Unported | |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/ | |
| dc.source | Scopus | |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969848812&partnerID=40&md5=0cd4ff7d2291f240806ee925c05f198d | |
| dc.title | Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas | |
| dc.type | journal article | |
| dc.identifier.doi | 10.18632/oncotarget.8957 | |
| dc.relation.projectID | Instituto de Salud Carlos III/PI11/00929 | |
| dc.relation.projectID | PI13/00259 | |
| dc.relation.projectID | CP13/00013 | |
| dc.relation.publisherversion | http://dx.doi.org/10.18632/oncotarget.8957 | |
| dc.rights.accessRights | open access |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos [37549]
-
Investigaciones y Documentos OpenAIRE [8420]
Publicaciones resultado de proyectos financiados con fondos públicos -
Medicina [989]
Este ítem está sujeto a una licencia Creative Commons